These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 129153)

  • 21. The purification and kinetic properties of biophosphoglycerate synthase from horse red blood cells.
    Rose AB; Dube S
    Arch Biochem Biophys; 1976 Nov; 177(1):284-92. PubMed ID: 187124
    [No Abstract]   [Full Text] [Related]  

  • 22. Human bisphosphoglycerate mutase expressed in E coli: purification, characterization and structure studies.
    Calvin MC; Blouquit Y; Garel MC; Prehu MO; Cohen-Solal M; Rosa J; Rosa R
    Biochimie; 1990 May; 72(5):337-43. PubMed ID: 2145041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reassessment of the phosphoglycerate bypass enzymes in human erythrocytes.
    Hass LF; Miller KB
    Biochem Biophys Res Commun; 1975 Oct; 66(3):970-9. PubMed ID: 170941
    [No Abstract]   [Full Text] [Related]  

  • 24. Partial characterization of the inactive mutant form of human red cell bisphosphoglyceromutase and comparison with an alkylated form.
    Rosa R; Préhu MO; Albrecht-Ellmer K; Calvin MC
    Biochim Biophys Acta; 1983 Jan; 742(1):243-9. PubMed ID: 6297586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isolation and characterization of an active site phosphohistidine peptide from human erythrocyte bisphosphoglycerate synthase.
    Hass LF; Place AR; Miller KB; Powers DA
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1570-6. PubMed ID: 6251847
    [No Abstract]   [Full Text] [Related]  

  • 26. Multifunctional enzyme, bisphosphoglyceromutase/2,3-bisphosphoglycerate phosphatase/phosphoglyceromutase, from human erythrocytes. Evidence for a common active site.
    Ikura K; Sasaki R; Narita H; Sugimoto E; Chiba H
    Eur J Biochem; 1976 Jul; 66(3):515-22. PubMed ID: 182493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologic and genetic alterations in human red cell DPGM.
    Koler RD; McClung MR; Peterson LL; Jones MB
    Hemoglobin; 1980; 4(5-6):593-600. PubMed ID: 6254918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2, 3-diphosphoglycerate mutase from human erythrocytes.
    Rose ZB
    Methods Enzymol; 1975; 42():450-4. PubMed ID: 166276
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunochemical and enzymatic properties of bisphosphoglyceromutase/phosphatase and phosphoglyceromutase from human erythrocytes.
    Ikura K; Narita H; Sasaki R; Chiba H
    Eur J Biochem; 1978 Aug; 89(1):23-31. PubMed ID: 212268
    [No Abstract]   [Full Text] [Related]  

  • 30. The phosphorylation of diphosphoglycerate mutase.
    Rose ZB; Whalen RG
    J Biol Chem; 1973 Mar; 248(5):1513-9. PubMed ID: 4694722
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for structural homology between human red cell phosphoglycerate mutase and 2,3-bisphosphoglycerate synthase.
    Hass LF; Kappel WK; Miller KB; Engle RL
    J Biol Chem; 1978 Jan; 253(1):77-81. PubMed ID: 201624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of 2,3-diphosphoglycerate and 2,3-diphosphoglycerate mutase in various mammals.
    Chemtob S; Gibb W; Bard H
    Biol Neonate; 1980; 38(1-2):36-9. PubMed ID: 6248136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphoglycerate mutase and pyruvate kinase activities during maturation of reticulocytes and ageing of erythrocytes.
    Luque J; Delgado MD; Rodriguez-Horche P; Company MT; Pinilla M
    Biosci Rep; 1987 Feb; 7(2):113-9. PubMed ID: 2820524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biosynthesis of 2,3-diphosphoglycerate by monophosphoglycerate mutase from muscle and erythrocytes.
    Laforet MT; Butterfield JB; Alpers JB
    Arch Biochem Biophys; 1974 Nov; 165(1):179-87. PubMed ID: 4441072
    [No Abstract]   [Full Text] [Related]  

  • 35. Red cell phosphoglycerate mutase and bisphosphoglycerate synthase: controlled modifications in coulombic properties in vitro.
    Hass LF; Miller KB; Fujii CC
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1602-8. PubMed ID: 212071
    [No Abstract]   [Full Text] [Related]  

  • 36. Hybrid forms of phosphoglycerate mutase and 2,3-bisphosphoglycerate synthase-phosphatase.
    Pons G; Bartrons R; Carreras J
    Biochem Biophys Res Commun; 1985 Jun; 129(3):658-63. PubMed ID: 2990463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis.
    Travis SF; Martinez J; Garvin J; Atwater J; Gillmer P
    Blood; 1978 Jun; 51(6):1107-16. PubMed ID: 148301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of multiple molecular forms of human red cell phosphoglycerate mutase and 2,3-bisphosphoglycerate synthase by isoelectric focusing.
    Hass LF; Miller KB
    J Biol Chem; 1978 Jun; 253(11):3798-803. PubMed ID: 206552
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in glycolytic enzyme activities in aging erythrocytes fractionated by counter-current distribution in aqueous polymer two-phase systems.
    Jimeno P; Garcia-Perez AI; Luque J; Pinilla M
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):237-43. PubMed ID: 1656939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of thyroid hormones and other kinetic modifiers on bisphosphoglyceromutase from human erythrocytes.
    Lappin TR; Elmore DT
    Biochem Pharmacol; 1980 Feb; 29(4):517-20. PubMed ID: 6245653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.